Compare OVID & BDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OVID | BDN |
|---|---|---|
| Founded | 2014 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 562.5M | 506.3M |
| IPO Year | 2017 | 1995 |
| Metric | OVID | BDN |
|---|---|---|
| Price | $2.19 | $2.67 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 12 | 5 |
| Target Price | ★ $6.02 | $3.00 |
| AVG Volume (30 Days) | 1.6M | ★ 1.7M |
| Earning Date | 11-11-2026 | 10-21-2026 |
| Dividend Yield | N/A | ★ 11.90% |
| EPS Growth | 3.90 | ★ 9.65 |
| EPS | ★ N/A | N/A |
| Revenue | $7,252,000.00 | ★ $484,454,000.00 |
| Revenue This Year | N/A | $12.99 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1181.27 | N/A |
| 52 Week Low | $1.18 | $2.47 |
| 52 Week High | $3.11 | $3.89 |
| Indicator | OVID | BDN |
|---|---|---|
| Relative Strength Index (RSI) | 34.35 | 28.48 |
| Support Level | $2.18 | N/A |
| Resistance Level | $2.79 | $3.31 |
| Average True Range (ATR) | 0.13 | 0.07 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 11.69 | 8.06 |
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Brandywine Realty Trust engaged in the acquisition, development, redevelopment, ownership, management, and operation of a portfolio of office, life science/lab, residential, and mixed-use properties. The company owned and managed properties within five segments. The Philadelphia CBD segment includes properties located in the City of Philadelphia in Pennsylvania. The Pennsylvania Suburbs segment includes properties in Chester, Delaware and Montgomery counties in the Philadelphia suburbs. The Austin, Texas segment includes properties in the City of Austin, Texas. The Metropolitan Washington, D.C. segment includes properties in Northern Virginia, Washington, D.C. and Southern Maryland. The Other segment includes properties in Camden County, New Jersey and New Castle County, Delaware.